Mission Raises $15m and Expands its Relationship with Pfizer
07/06/20, 8:01 AM
Location
mamaroneckMoney raised
$15 million
Mission Therapeutics (“Mission”), a drug discovery and development company focused on selectively inhibiting deubiquitylating enzymes (DUBs), today announced that it has raised $15m (£12m) in equity investment. The round was led by existing investor Pfizer Ventures, the venture capital arm of Pfizer Inc. (“Pfizer”)(NYSE: PFE).
Company Info
Location
mamaroneck, new york, united states
Additional Info
®Co-founded in 2009 by a group of world-class athletes including Serena Williams, Dwyane Wade and Drew Brees, MISSION® is pioneering temperature technologies to improve performance and recovery for active consumers everywhere. With thoughtful design and state-of-the-art technology, MISSION® has developed a broad portfolio of temperature technologies designed to help you do more, achieve more and enjoy more. All of MISSION's products are made from lightweight, ultra-soft, patented and proprietary fabrics with technologies designed to keep you comfortable in all conditions. For more information, visit www.mission.com and follow us @missioncooling on Instagram and Facebook.